Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

As Obesity Care Week (OCW) 2025 comes to a close, organizers and supporters are reflecting on a week of impactful advocacy and awareness. The year's theme, "Commit to Care," inspired widespread ...

Minnesota lawmakers are once again calling on insurance companies to cover anti-obesity medications like Ozempic and Wegovy ...

ROCKVILLE, MD – The Obesity Society (TOS) acknowledges the U.S. Food and Drug Administration's (FDA) recent announcement declaring the end of shortages for Novo Nordisk's Wegovy and Ozempic; two ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...

Bayer BAYRY announced its fourth-quarter and full-year 2024 results. AbbVie ABBV announced a licensing deal with Danish firm ...